Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 30;18(6):2138047.
doi: 10.1080/21645515.2022.2138047. Epub 2022 Nov 7.

Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature"

Affiliations
Review

Models of determinants of COVID-19 vaccine hesitancy in non-pregnant and pregnant population: Review of current literature"

Lauren Tostrud et al. Hum Vaccin Immunother. .

Abstract

Vaccination has proven to be the most effective tool in controlling the COVID-19 pandemic. While pregnant individuals are considered to be a high-risk population and are more likely to experience adverse effects from COVID-19, vaccination rates among pregnant individuals are significantly lower than in the general population. The Health Belief Model (HBM), Theory of Planned Behavior (TPB), 3C model, 5C model, and 5A model have been used to assess vaccination hesitancy behaviors. In this paper, we review the use of each of these models to address vaccine hesitancy, with a focus on the pregnant population and the COVID-19 vaccine. The HBM, TPB, 3C model, and 5C model have demonstrated great versatility in their ability to evaluate, explain, and modify vaccine hesitancy and behavior. Up to date, the HBM and 3C models appear to be the most effective models to study and address vaccination hesitancy within the pregnant persons.

Keywords: 3C model; 5A model; 5C model; Vaccine hesitancy; health belief model; pregnancy; theory of planned behavior.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
The “Health Belief Model.” Figure reproduced from Rosenstock, Health Education Monographs, 1974. Model details the individual perceptions and modifying factors that influence the likelihood of action regarding vaccination behaviors.
Figure 2.
Figure 2.
Theory of Planned Behavior. Figure reproduced from Ajzen, Organizational Behavior and Human Decision Processes, 1991. Figure details the relationship between various constructs and their ability to influence vaccination intention and overall behavior.
Figure 3.
Figure 3.
SAGE Working Group Matrix of Vaccine Hesitancy. Figure reproduced from Larson, Jarrett, Eckersberger, Smith, and Paterson, Vaccine, 2014. Figure demonstrates the determinants of vaccine hesitancy as laid out by the SAGE Working Group.
Figure 4.
Figure 4.
3C model. Figure reproduced from the World Health Organization’s SAGE vaccine hesitancy Working Group, Report of the SAGE working group on vaccine hesitancy, 2014. Figure demonstrates the factors that contribute to the 3C model.
Figure 5.
Figure 5.
The 5C Model. Figure reproduced from Turner, Larson, Dubé, and Fisher, Journal of Allergy and Clinical Immunology: In Practice, 2021. Figure details the five factors of the 5C model and the various elements that contribute to their composition.

Similar articles

Cited by

References

    1. COVID Data Tracker (CDC) . Centers for Disease control and prevention. 2020. [accessed 2022 Apr 4]. https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women.
    1. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, Roggero P, Prefumo F, Silva Do Vale M, Cardona-Perez JA, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr. 2021. Aug. [accessed 2021Dec 18];175(8):1–15. doi:10.1001/jamapediatrics.2021.1050. - DOI - PMC - PubMed
    1. Fu W, Sivajohan B, McClymont E, Albert A, Elwood C, Ogilvie G, Money D.. Systematic review of the safety, immunogenicity, and effectiveness of COVID-19 vaccines in pregnant and lactating individuals and their infants. Int J Gynaecol Obstet. 2022. Mar;156(3):406–17. doi:10.1002/ijgo.14008. - DOI - PMC - PubMed
    1. Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu TG, Boyce TG, Daley MF, Fuller CC, Getahun D, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, December 15, 2020-July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022. Jan;71(1):26–30. doi:10.15585/mmwr.mm7101e1. - DOI - PMC - PubMed
    1. Morgan JA, Biggio JR Jr, Martin JK, Mussarat N, Chawla HK, Puri P, Williams FB. Maternal outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated compared with unvaccinated pregnant patients. Obstet Gynecol. 2022. Jan;139(1):107–09. doi:10.1097/AOG.000000000000462. - DOI - PubMed

Substances